Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 12/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.33 |
| ▸ | DPP4 | P27487 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL369325 | 0.92 | GSR (0.50) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL369324 | 0.92 | GSR (0.50) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL11667283 | 0.92 | GSR (0.50) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Hydrochloric Acid SCHEMBL11554718 | 0.91 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Hydrochloric Acid SCHEMBL11554720 | 0.91 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5203652 | 0.87 | GSR (0.42) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5203658 | 0.87 | GSR (0.42) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5203643 | 0.87 | GSR (0.42) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL8822125 | 0.81 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL7950462 | 0.80 | TDP1 (0.39) | GSRDPP7TDP1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1134246-B1 | Polyisocyanate | BASF SE (DE) | 2012-09-26 | — | — | EP | claimed |
| EP-1794204-B1 | WATER-DISPERSIBLE HIGHLY FUNCTIONAL POLYISOCYANATES | BASF SE (DE) | 2011-03-16 | — | — | EP | claimed |
| US-7339020-B2 | High-functionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-04 | — | — | US | claimed |
| US-20070270543-A1 | Water-Dispersible Highly Functional polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-22 | — | — | US | claimed |
| EP-1134247-B1 | Highfunctionality polyisocyanates | BASF AG (DE) | 2007-09-12 | — | — | EP | claimed |
| EP-1054030-B1 | Linear oligo- and polyurethanes having defined structure, their manufacture and uses | BASF AG (DE) | 2002-12-04 | — | — | EP | claimed |
| US-6465596-B1 | Linear oligourethanes and polyurethanes having a defined structure, their preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-15 | — | — | US | claimed |
| US-6416686-B2 | Polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-09 | — | — | US | claimed |
| US-20020007036-A1 | High-functionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-17 | — | — | US | claimed |
| US-20010025096-A1 | Polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-27 | — | — | US | claimed |
| US-20010005738-A1 | Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-28 | — | — | US | claimed |
| US-4404347-A | Polyisocyanate cross-linked polymers containing cellulosic component | NIPPON PAINT CO., LTD. (JP) | 1983-09-13 | — | — | US | claimed |
| EP-3568016-B1 | MICROCAPSULES COMPRISING CINMETHYLIN IN THE CORE AND A POLYUREA DERIVED FROM DIPHENYLMETHANE DIISOCYANATE OR AN OLIGOMER THEREOF | BASF AGRO BV (NL) | 2024-07-17 | — | — | EP | disclosed |
| US-20240110015-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX B.V. (NL) | 2024-04-04 | — | — | US | disclosed |
| US-11884781-B2 | Supramolecular biomedical polymers | SUPRAPOLIX B.V. (NL) | 2024-01-30 | — | — | US | disclosed |
| EP-3713990-B1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX BV (NL) | 2023-08-02 | — | — | EP | disclosed |
| US-20010025096-A1 | Polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-27 | — | — | US | disclosed |
| US-20010005738-A1 | Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-28 | — | — | US | disclosed |
| US-4404347-A | Polyisocyanate cross-linked polymers containing cellulosic component | NIPPON PAINT CO., LTD. (JP) | 1983-09-13 | — | — | US | disclosed |
| US-4401801-A | Coating and dressing agents for leather and leather substitutes based on polyurethane urea coating compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1983-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007036-A1 | High-functionality polyisocyanates | PCBP1, C9, CYP1B1 | GSR 1520/4885GNAI3 1365/4885GNAO1 2468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.